Skip to content

Efficacy study of topical formulations (BH07, BH08)

Efficacy study of topical formulations (BH07, BH08) - Efficacy study of topical formulations (BH07, BH08)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037856
Enrollment
52
Registered
2019-10-01
Start date
2019-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Applying test formulation (BH07) up to ten a day for 4 weeks -&gt
Post-observation period for 1week Washout for 1week -&gt
Applying test formulation (BH08) up to ten a day for 4 weeks -&gt
Applying control formulation up to ten a day for 4 weeks -&gt
Post-observation period for 1week

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Subjects with dry skin on the hands

Exclusion criteria

Exclusion criteria: -Subjects with congenital skin diseases -Ambulatory patient or subjects who are applying prescription drugs on the hands -Subjects with any complications which affect the results of this study -Subjects with menopausal trouble or on menopausal hormone therapy -Pregnancies, lactations or subjects with suspicion of pregnancy. -Subjects deemed inappropriate to participate in this study by person in charge of the examination

Design outcomes

Primary

MeasureTime frame
Transition of measured skin properties by instruments

Secondary

MeasureTime frame
Questionnaires for QOL

Countries

Japan

Contacts

Public ContactShotaro Ito

Kao Corporation Personal Health Care Products Research

itou.shoutarou@kao.com+81-285-68-9443

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026